
Eidos Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update
11.06.2018
Eidos Therapeutics to Host Conference Call and Webcast to Discuss Phase 2 Clinical Trial Results
10.29.2018
Eidos Therapeutics to Present at the Leerink Partners Roundtable Series: Rare Disease & Oncology
09.25.2018
Eidos Therapeutics Announces Publication of AG10 Molecular Design in Journal of Medicinal Chemistry
08.23.2018
Eidos Therapeutics Reports Second Quarter 2018 Financial Results and Provides Corporate Update
08.07.2018
BridgeBio Pharma launches CoA Therapeutics to Target Coenzyme-A for Rare Genetic Disorders
06.13.2018
news
Catch up on news from BridgeBio and its companies and follow developments about the promising treatments in our pipeline. Follow us on LinkedIn to keep up with all the latest news.
Links to an external site